Top-Rated StocksTop-RatedNASDAQ:RCM R1 RCM (RCM) Stock Forecast, Price & News $16.06 0.00 (0.00%) (As of 01:15 PM ET) Add Compare Share Share Today's Range$16.00▼$16.4050-Day Range$13.75▼$16.9152-Week Range$6.71▼$27.07Volume557,686 shsAverage Volume2.55 million shsMarket Capitalization$6.72 billionP/E RatioN/ADividend YieldN/APrice Target$17.44 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability R1 RCM MarketRank™ ForecastAnalyst RatingModerate Buy2.87 Rating ScoreUpside/Downside7.5% Upside$17.44 Price TargetShort InterestBearish10.94% of Float Sold ShortDividend StrengthN/ASustainability-1.33Upright™ Environmental ScoreNews Sentiment0.58Based on 4 Articles This WeekInsider TradingSelling Shares$327,200 Sold Last QuarterProj. Earnings Growth337.50%From $0.08 to $0.35 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.93 out of 5 starsBusiness Services Sector238th out of 346 stocksManagement Services Industry5th out of 6 stocks 1.4 Analyst's Opinion Consensus RatingR1 RCM has received a consensus rating of Buy. The company's average rating score is 2.87, and is based on 13 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $17.44, R1 RCM has a forecasted upside of 7.5% from its current price of $16.22.Amount of Analyst CoverageR1 RCM has only been the subject of 3 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted10.94% of the float of R1 RCM has been sold short.Short Interest Ratio / Days to CoverR1 RCM has a short interest ratio ("days to cover") of 9.2.Change versus previous monthShort interest in R1 RCM has recently decreased by 1.03%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldR1 RCM does not currently pay a dividend.Dividend GrowthR1 RCM does not have a long track record of dividend growth. Previous Next 3.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreR1 RCM has received a 45.11% net impact score from Upright. R1 Rcm seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Documentation software for clinicians", "Personal health record software", and "Hospital cost management software" products. See details.Environmental SustainabilityThe Environmental Impact score for R1 RCM is -1.33. Previous Next 1.4 News and Social Media Coverage News SentimentR1 RCM has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.News Coverage This WeekMarketBeat has tracked 4 news articles for R1 RCM this week, compared to 5 articles on an average week. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, R1 RCM insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $327,200.00 in company stock.Percentage Held by Insiders37.00% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions97.09% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for R1 RCM are expected to grow by 337.50% in the coming year, from $0.08 to $0.35 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of R1 RCM is -70.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of R1 RCM is -70.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioR1 RCM has a PEG Ratio of 11.66. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioR1 RCM has a P/B Ratio of 2.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About R1 RCM (NASDAQ:RCM) StockR1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Murray, UT.Read More Receive RCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter. Email Address RCM Stock News HeadlinesMay 24, 2023 | americanbankingnews.comR1 RCM Inc. (NASDAQ:RCM) Receives $17.44 Consensus Target Price from AnalystsMay 23, 2023 | uk.finance.yahoo.comGlobal Healthcare Revenue Cycle Management Market is projected to grow at a Healthy CAGR of ~11-12% by 2027May 30, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.May 22, 2023 | americanbankingnews.comBank of America Raises R1 RCM (NASDAQ:RCM) Price Target to $22.00May 21, 2023 | americanbankingnews.comR1 RCM (NASDAQ:RCM) Shares Gap Up Following Analyst UpgradeMay 19, 2023 | markets.businessinsider.comR1 RCM (RCM) Receives a Buy from Bank of America SecuritiesMay 19, 2023 | cnbc.comBuy this medical billing stock with more than 30% upside, Bank of America saysMay 16, 2023 | marketwatch.com2023, Healthcare Revenue Cycle Management (RCM) Market | Global Industry Analysis Till 2030May 30, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.May 15, 2023 | msn.comR1 RCM's Return On Capital Employed OverviewMay 11, 2023 | markets.businessinsider.comRobert W. Baird Reaffirms Their Buy Rating on R1 RCM (RCM)May 10, 2023 | americanbankingnews.comResearch Analysts Issue Forecasts for R1 RCM Inc.'s Q3 2023 Earnings (NASDAQ:RCM)May 10, 2023 | americanbankingnews.comDeutsche Bank Aktiengesellschaft Increases R1 RCM (NASDAQ:RCM) Price Target to $18.00May 9, 2023 | marketwatch.comHealthcare Revenue Cycle Management (RCM) Software Market [2023-2031]| Explore the Future Growth of Industry: An Intelligence ReportMay 9, 2023 | americanbankingnews.comR1 RCM Inc. to Post Q2 2023 Earnings of $0.00 Per Share, KeyCorp Forecasts (NASDAQ:RCM)May 8, 2023 | marketwatch.comRevenue Cycle Management (RCM) System Market 2023 (New Report) is Poised to Experience Huge Global Growth from 2023 to 2031May 7, 2023 | seekingalpha.comR1 RCM Inc. 2023 Q1 - Results - Earnings Call PresentationMay 6, 2023 | msn.comMorgan Stanley Maintains R1 RCM (RCM) Equal-Weight RecommendationMay 6, 2023 | finance.yahoo.comR1 RCM Inc. Beat Analyst Profit Forecasts, And Analysts Have New EstimatesMay 5, 2023 | msn.comTruist Securities Maintains R1 RCM (RCM) Hold RecommendationMay 5, 2023 | marketwatch.comHealthcare RCM Outsourcing Market Future Growth and Business Opportunities 2023 | Updated ReportMay 4, 2023 | finance.yahoo.comR1 RCM Inc. (RCM) Reports Break-Even Earnings for Q1May 4, 2023 | finanznachrichten.deR1 RCM Inc.: R1 RCM Reports First Quarter 2023 ResultsMay 4, 2023 | msn.comR1 RCM GAAP EPS of $0.00 beats by $0.02, revenue of $545.6M misses by $2.61MMay 4, 2023 | msn.comR1 RCM: Q1 Earnings InsightsMay 4, 2023 | finance.yahoo.comR1 RCM Reports First Quarter 2023 ResultsMay 2, 2023 | americanbankingnews.comR1 RCM (RCM) Set to Announce Quarterly Earnings on ThursdaySee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive RCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter. Email Address RCM Company Calendar Last Earnings2/16/2023Today5/30/2023Next Earnings (Estimated)8/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Management services Sub-IndustryHealth Care Services SectorBusiness Services Current SymbolNASDAQ:RCM Previous SymbolNYSE:RCM CUSIP00438V10 CIK1472595 Webwww.r1rcm.com Phone(312) 324-7820Fax302-655-5049Employees27,800Year Founded2003Price Target and Rating Average Stock Price Forecast$17.44 High Stock Price Forecast$25.00 Low Stock Price Forecast$10.00 Forecasted Upside/Downside+8.6%Consensus RatingModerate Buy Rating Score (0-4)2.87 Research Coverage15 Analysts Profitability EPS (Most Recent Fiscal Year)($0.23) Trailing P/E RatioN/A Forward P/E Ratio200.75 P/E Growth11.66Net Income$-57,600,000.00 Net Margins-4.41% Pretax Margin-4.91% Return on Equity-1.02% Return on Assets-0.55% Debt Debt-to-Equity Ratio0.63 Current Ratio1.71 Quick Ratio1.71 Sales & Book Value Annual Sales$1.81 billion Price / Sales3.72 Cash Flow$0.28 per share Price / Cash Flow56.69 Book Value$6.53 per share Price / Book2.46Miscellaneous Outstanding Shares418,200,000Free Float263,468,000Market Cap$6.72 billion OptionableNot Optionable Beta0.84 Social Links Key ExecutivesLee RivasChief Executive Officer & DirectorJohn SparbyPresidentKristina BourkeExecutive Vice President-OperationsJennifer WilliamsChief Financial Officer & EVPHarvey EwingChief Information Officer & Executive VPKey CompetitorsGartnerNYSE:ITAvis Budget GroupNASDAQ:CARCore & MainNYSE:CNMElasticNYSE:ESTCStantecNYSE:STNView All CompetitorsInsiders & InstitutionsProShare Advisors LLCSold 4,021 shares on 5/26/2023Ownership: 0.006%Capital Impact Advisors LLCSold 12,909 shares on 5/23/2023Ownership: 0.011%Ameriprise Financial Inc.Sold 26,271 shares on 5/22/2023Ownership: 0.257%JPMorgan Chase & Co.Bought 254,357 shares on 5/18/2023Ownership: 0.137%New York State Common Retirement FundSold 26,461 shares on 5/18/2023Ownership: 0.019%View All Insider TransactionsView All Institutional Transactions RCM Stock - Frequently Asked Questions Should I buy or sell R1 RCM stock right now? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last twelve months. There are currently 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" RCM shares. View RCM analyst ratings or view top-rated stocks. What is R1 RCM's stock price forecast for 2023? 15 equities research analysts have issued twelve-month price objectives for R1 RCM's stock. Their RCM share price forecasts range from $10.00 to $25.00. On average, they expect the company's stock price to reach $17.44 in the next twelve months. This suggests a possible upside of 8.6% from the stock's current price. View analysts price targets for RCM or view top-rated stocks among Wall Street analysts. How have RCM shares performed in 2023? R1 RCM's stock was trading at $10.95 at the start of the year. Since then, RCM stock has increased by 46.7% and is now trading at $16.06. View the best growth stocks for 2023 here. When is R1 RCM's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023. View our RCM earnings forecast. How were R1 RCM's earnings last quarter? R1 RCM Inc. (NASDAQ:RCM) announced its quarterly earnings data on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.06. The healthcare provider had revenue of $532.80 million for the quarter, compared to analyst estimates of $519.28 million. R1 RCM had a negative trailing twelve-month return on equity of 1.02% and a negative net margin of 4.41%. The business's revenue for the quarter was up 33.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.11 EPS. What ETFs hold R1 RCM's stock? ETFs with the largest weight of R1 RCM (NASDAQ:RCM) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Thrivent Small-Mid Cap ESG ETF (TSME), Fidelity Digital Health ETF (FDHT), SPDR S&P Health Care Services ETF (XHS), ERShares NextGen Entrepreneurs ETF (ERSX), Invesco NASDAQ Next Gen 100 ETF (QQQJ), RiverNorth Patriot ETF (FLDZ) and BlackRock Future Health ETF (BMED). What guidance has R1 RCM issued on next quarter's earnings? R1 RCM issued an update on its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.28 billion-$2.33 billion, compared to the consensus revenue estimate of $2.31 billion. What is Joseph Flanagan's approval rating as R1 RCM's CEO? 253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees. What other stocks do shareholders of R1 RCM own? Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN). What is R1 RCM's stock symbol? R1 RCM trades on the NASDAQ under the ticker symbol "RCM." Who are R1 RCM's major shareholders? R1 RCM's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (4.22%), FMR LLC (1.91%), Sachem Head Capital Management LP (1.78%), American Century Companies Inc. (1.77%), Bank of New York Mellon Corp (1.53%) and State Street Corp (1.18%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Alex Mandl, Gary Steven Long, John M Sparby, Joseph Gerard Flanagan, Lee Rivas, Michael C Feiner and Richard B Jr Evans. View institutional ownership trends. How do I buy shares of R1 RCM? Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is R1 RCM's stock price today? One share of RCM stock can currently be purchased for approximately $16.06. How much money does R1 RCM make? R1 RCM (NASDAQ:RCM) has a market capitalization of $6.72 billion and generates $1.81 billion in revenue each year. The healthcare provider earns $-57,600,000.00 in net income (profit) each year or ($0.23) on an earnings per share basis. How many employees does R1 RCM have? The company employs 27,800 workers across the globe. Does R1 RCM have any subsidiaries? The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.Read More How can I contact R1 RCM? R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The official website for the company is www.r1rcm.com. The healthcare provider can be reached via phone at (312) 324-7820, via email at arahim@r1rcm.com, or via fax at 302-655-5049. This page (NASDAQ:RCM) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding R1 RCM Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.